Exploring the current landscape of chitosan-based hybrid nanoplatforms as cancer theragnostic

R Nair, P Paul, I Maji, U Gupta, S Mahajan… - Carbohydrate …, 2024 - Elsevier
In the last decade, investigators have put significant efforts to develop several diagnostic
and therapeutic strategies against cancer. Many novel nanoplatforms, including lipidic …

Implications of protein-and peptide-based nanoparticles as potential vehicles for anticancer drugs

AO Elzoghby, MM Elgohary, NM Kamel - Advances in protein chemistry …, 2015 - Elsevier
Protein-based nanocarriers have gained considerable attention as colloidal carrier systems
for the delivery of anticancer drugs. Protein nanocarriers possess various advantages …

Ligand-based targeted therapy: a novel strategy for hepatocellular carcinoma

M Li, W Zhang, B Wang, Y Gao, Z Song… - International Journal of …, 2016 - Taylor & Francis
Hepatocellular carcinoma (HCC) is the most common primary liver cancer with high
morbidity and mortality worldwide. Chemotherapy is recommended to patients with …

Nanocarrier-based tumor-targeting drug delivery systems for hepatocellular carcinoma treatments: Enhanced therapeutic efficacy and reduced drug toxicity

T Tian, J Ruan, J Zhang, CX Zhao… - Journal of biomedical …, 2022 - ingentaconnect.com
Hepatocellular carcinoma (HCC), due to the lack of efficient diagnostic methods and short of
available treatments, becomes the third main cause of cancer deaths. Novel treatments for …

Asialoglycoprotein receptor targeted delivery of doxorubicin nanoparticles for hepatocellular carcinoma

S Pranatharthiharan, MD Patel, VC Malshe, V Pujari… - Drug …, 2017 - Taylor & Francis
We report asialoglycoprotein receptor (ASGPR)-targeted doxorubicin hydrochloride (Dox)
nanoparticles (NPs) for hepatocellular carcinoma (HCC). Polyethylene sebacate (PES) …

[HTML][HTML] Chitosan nanoparticle toxicity: A comprehensive literature review of in vivo and in vitro assessments for medical applications

LH Zoe, SR David, R Rajabalaya - Toxicology Reports, 2023 - Elsevier
Abstract Topic Definition This literature review aims to update the current knowledge on
toxicity of chitosan nanoparticles, compare the recent findings and identify the gaps with …

[HTML][HTML] Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma

J Varshosaz, M Farzan - World Journal of Gastroenterology, 2015 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is the 5 th most common malignancy which is responsible
for more than half million annual mortalities; also, it is the third leading cause of cancer …

Recent advances of nanomedicines for liver cancer therapy

X Chi, K Liu, X Luo, Z Yin, H Lin, J Gao - Journal of materials chemistry …, 2020 - pubs.rsc.org
Liver cancer is one of the most prevalent cancers and the third leading cause of cancer-
related deaths worldwide. Liver cancer is insensitive to chemotherapeutic drugs due to its …

Inhalable dual-targeted hybrid lipid nanocore–protein shell composites for combined delivery of genistein and all-trans retinoic acid to lung cancer cells

NM Kamel, MW Helmy, EZ Abdelfattah… - ACS Biomaterials …, 2019 - ACS Publications
Localized pulmonary delivery of anticancer agents to lungs has proven to be pioneering
approach for lung cancer therapy. Hybrid lipid nanocore-protein shell nanoparticles …

Protein-polysaccharide nanohybrids: Hybridization techniques and drug delivery applications

M Gaber, MT Mabrouk, MS Freag, SK Khiste… - European Journal of …, 2018 - Elsevier
Complex nanosystems fabricated by hybridization of different types of materials such as
lipids, proteins, or polysaccharides are usually superior to simple ones in terms of features …